CELLDEX THERAPEUTICS INC NEW

Ticker: CLDX CUSIP: 15117B202 Class: Common Stock

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 118,205 Value ($000) $3,210 Avg Close $26.34 Range $22.10 - $30.50

Q1 2024

Shares 8,158 Value ($000) $342 Avg Close $41.06 Range $34.65 - $53.18

Q4 2023

Shares 28,538 Value ($000) $1,132 Avg Close $29.41 Range $22.11 - $41.47

Q3 2023

Shares 18,155 Value ($000) $500 Avg Close $31.35 Range $24.89 - $38.33

Q1 2023

Shares 42,636 Value ($000) $1,534 Avg Close $43.15 Range $33.83 - $48.40

Q4 2022

Shares 57,910 Value ($000) $2,581 Avg Close $35.70 Range $27.01 - $46.04

Q3 2022

Shares 80,650 Value ($000) $2,267 Avg Close $30.66 Range $21.65 - $38.52

Q3 2021

Shares 12,117 Value ($000) $654 Avg Close $46.92 Range $28.30 - $56.17

Q2 2021

Shares 14,533 Value ($000) $486 Avg Close $27.45 Range $19.71 - $35.69

Q4 2020

Shares 37,346 Value ($000) $654 Avg Close $18.00 Range $14.40 - $23.40

Q3 2020

Shares 51,579 Value ($000) $765 Avg Close $11.71 Range $9.59 - $16.19

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	118,205	$3,210	$26.34	$22.10 - $30.50
Q1 2024	8,158	$342	$41.06	$34.65 - $53.18
Q4 2023	28,538	$1,132	$29.41	$22.11 - $41.47
Q3 2023	18,155	$500	$31.35	$24.89 - $38.33
Q1 2023	42,636	$1,534	$43.15	$33.83 - $48.40
Q4 2022	57,910	$2,581	$35.70	$27.01 - $46.04
Q3 2022	80,650	$2,267	$30.66	$21.65 - $38.52
Q3 2021	12,117	$654	$46.92	$28.30 - $56.17
Q2 2021	14,533	$486	$27.45	$19.71 - $35.69
Q4 2020	37,346	$654	$18.00	$14.40 - $23.40
Q3 2020	51,579	$765	$11.71	$9.59 - $16.19